165 related articles for article (PubMed ID: 37958190)
41. Long Axial Field-of-View PET for Ultra-Low-Dose Imaging of Non-Hodgkin Lymphoma during Pregnancy.
van Sluis J; Bellido M; Glaudemans AWJM; Slart RHJA
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611320
[TBL] [Abstract][Full Text] [Related]
42. Total Body PET-CT Protocols in Oncology.
Dimitrakopoulou-Strauss A; Pan L; Sachpekidis C
Semin Nucl Med; 2024 Jun; ():. PubMed ID: 38851935
[TBL] [Abstract][Full Text] [Related]
43. Impact of PET acquisition durations on image quality and lesion detectability in whole-body
Noto B; Büther F; Auf der Springe K; Avramovic N; Heindel W; Schäfers M; Allkemper T; Stegger L
EJNMMI Res; 2017 Dec; 7(1):12. PubMed ID: 28168589
[TBL] [Abstract][Full Text] [Related]
44. Combined [68 Ga]Ga-PSMA-11 and low-dose 2-[18F]FDG PET/CT using a long-axial field of view scanner for patients referred for [177Lu]-PSMA-radioligand therapy.
Alberts I; Schepers R; Zeimpekis K; Sari H; Rominger A; Afshar-Oromieh A
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):951-956. PubMed ID: 36136102
[TBL] [Abstract][Full Text] [Related]
45. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
46. Optimization of PET protocol and interrater reliability of
Piron S; De Man K; Schelfhout V; Van Laeken N; Kersemans K; Achten E; De Vos F; Ost P
EJNMMI Res; 2020 Feb; 10(1):14. PubMed ID: 32095919
[TBL] [Abstract][Full Text] [Related]
47. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.
Everaert H; Vanhove C; Lahoutte T; Muylle K; Caveliers V; Bossuyt A; Franken PR
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1615-9. PubMed ID: 14504831
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of optimal acquisition duration or injected activity for pediatric 18F-FDG PET/CT.
Alessio AM; Sammer M; Phillips GS; Manchanda V; Mohr BC; Parisi MT
J Nucl Med; 2011 Jul; 52(7):1028-34. PubMed ID: 21680684
[TBL] [Abstract][Full Text] [Related]
49. Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study.
Fragoso Costa P; Jentzen W; SÜßELBECK F; Fendler WP; Rischpler C; Herrmann K; Conti M; Kersting D; Weber M
Q J Nucl Med Mol Imaging; 2023 Mar; 67(1):57-68. PubMed ID: 34309334
[TBL] [Abstract][Full Text] [Related]
50. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.
Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the partial volume effect along the axial field-of-view of the Biograph Vision Quadra total-body PET/CT system for multiple isotopes.
Mannheim JG; Rausch I; Conti M; la Fougère C; Schmidt FP
EJNMMI Phys; 2023 May; 10(1):33. PubMed ID: 37243869
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
[TBL] [Abstract][Full Text] [Related]
53. Total-body parametric imaging using the Patlak model: Feasibility of reduced scan time.
Wu Y; Feng T; Shen Y; Fu F; Meng N; Li X; Xu T; Sun T; Gu F; Wu Q; Zhou Y; Han H; Bai Y; Wang M
Med Phys; 2022 Jul; 49(7):4529-4539. PubMed ID: 35394071
[TBL] [Abstract][Full Text] [Related]
54. Optimized low-dose positron emission tomography/computed tomography schemes in pediatric tumor patients: a randomized clinical trial.
Yu S; Qian Z; Liu H; Fan R; Long X; Li B; Zhang Q; Wang Y; Cao L; Zhou R; Hou D; Gao D; Liu L; Chen X
Transl Pediatr; 2022 Sep; 11(9):1510-1520. PubMed ID: 36247895
[TBL] [Abstract][Full Text] [Related]
55. The impact of acquisition time on image quality in whole-body 18F-FDG PET/CT for cancer staging.
Hausmann D; Dinter DJ; Sadick M; Brade J; Schoenberg SO; Büsing K
J Nucl Med Technol; 2012 Dec; 40(4):255-8. PubMed ID: 23071347
[TBL] [Abstract][Full Text] [Related]
56. Optimal clinical protocols for total-body 18F-FDG PET/CT examination under different activity administration plans.
Huang Y; Wang M; Jiang L; Wang L; Chen L; Wang Q; Feng J; Wang J; Xu W; Wu H; Han Y
EJNMMI Phys; 2023 Feb; 10(1):14. PubMed ID: 36808378
[TBL] [Abstract][Full Text] [Related]
57. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
[TBL] [Abstract][Full Text] [Related]
58. Optimization of a shorter variable-acquisition time for legs to achieve true whole-body PET/CT images.
Umeda T; Miwa K; Murata T; Miyaji N; Wagatsuma K; Motegi K; Terauchi T; Koizumi M
Australas Phys Eng Sci Med; 2017 Dec; 40(4):861-868. PubMed ID: 29098601
[TBL] [Abstract][Full Text] [Related]
59. A Case of Clinical Uncertainty Solved: Giant Cell Arteritis with Polymyalgia Rheumatica Swiftly Diagnosed with Long Axial Field of View PET.
Nienhuis PH; van Sluis J; van Snick JH; Glaudemans AWJM; Meijering S; Brouwer E; Slart RHJA
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36359537
[TBL] [Abstract][Full Text] [Related]
60. Determination of the optimal acquisition protocol of breath-hold PET/CT for the diagnosis of thoracic lesions.
Mitsumoto K; Abe K; Sakaguchi Y; Zhang T; Tachiya Y; Ohya N; Baba S; Sasaki M
Nucl Med Commun; 2011 Dec; 32(12):1148-54. PubMed ID: 21968434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
